ARTICLE | Clinical News
PHP: Began Phase I double-blind, placebo-controlled trial in healthy volunteers to determine safety and tolerance of escalating doses
May 8, 1995 7:00 AM UTC
Apex Bioscience Inc., Research Triangle Park, N.C. Product: PHP, pyridoxylated hemoglobin polyoxyethylene, a scavenger of nitric oxide Indication: Acute hypotension mediated by nitric oxide (e.g. sept...